{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:42Z","timestamp":1759334682465,"version":"build-2065373602"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jfo.2021.08.002","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T02:19:00Z","timestamp":1632881940000},"page":"119-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ophtalmies paran\u00e9oplasiques"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2451-341X","authenticated-orcid":false,"given":"Z.","family":"B\u00f6cskei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Viinikka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7632-9687","authenticated-orcid":false,"given":"L.","family":"Dormegny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5176-580X","authenticated-orcid":false,"given":"K.","family":"Bigaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Speeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2011","series-title":"Paraneoplastic syndromes","author":"Darnell","key":"10.1016\/j.jfo.2021.08.002_bib0505"},{"key":"10.1016\/j.jfo.2021.08.002_bib0510","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2021.08.002_bib0515","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/ICU.0b013e3282f0b497","article-title":"Paraneoplastic syndromes in neuro-ophthalmology","volume":"18","author":"Alabduljalil","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0520","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1212\/CON.0000000000000788","article-title":"Paraneoplastic syndromes in neuro-ophthalmology","volume":"25","author":"Gordon","year":"2019","journal-title":"Contin Lifelong Learn Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0525","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12348-011-0028-8","article-title":"Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy","volume":"1","author":"Adamus","year":"2011","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2021.08.002_bib0530","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0535","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0540","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/annonc\/mdw126","article-title":"Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma","volume":"27","author":"Vallet","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0545","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/1346-8138.12982","article-title":"Bilateral diffuse uveal melanocytic proliferation with mucocutaneous pigmentation","volume":"42","author":"Tada","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0550","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962013000100001","article-title":"Paraneoplastic cutaneous manifestations: concepts and updates*","volume":"88","author":"da Silva","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0555","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome\u00a0\u2013\u00a0a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jfo.2021.08.002_bib0560","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.57.8.447","article-title":"Ophthalmic manifestations of dermatomyositis","volume":"57","author":"Backhouse","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2021.08.002_bib0565","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13256-019-2105-9","article-title":"Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report","volume":"13","author":"Shibata","year":"2019","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.jfo.2021.08.002_bib0570","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1378\/chest.123.2.627","article-title":"Paraneoplastic bilateral proptosis in a case of non-small cell lung cancer*","volume":"123","author":"Diacon","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jfo.2021.08.002_bib0575","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1055\/s-2007-1024131","article-title":"44j\u00e4hriger Patient mit Kardiakarzinom und paraneoplastischer Orbitopathie","volume":"123","author":"Eckel","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jfo.2021.08.002_bib0580","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2021.08.002_bib0585","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","article-title":"Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study","volume":"85","author":"Gozzard","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0590","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0595","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000494078","article-title":"Lambert-Eaton myasthenic syndrome caused by nivolumab in a patient with squamous cell lung cancer","volume":"10","author":"Nakatani","year":"2018","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0600","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNO.0b013e3181677fcc","article-title":"Neuro-ophthalmologic manifestations of paraneoplastic syndromes","volume":"28","author":"Ko","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0605","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ophtha.2011.10.008","article-title":"Blepharospasm and apraxia of eyelid opening associated with anti-Hu paraneoplastic antibodies","volume":"119","author":"Choe","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0610","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s00415-002-0913-z","article-title":"Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma","volume":"249","author":"Wirtz","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0615","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/eye.1990.61","article-title":"Ocular autonomic nerve function in Lambert-Eaton myasthenic syndrome","volume":"4","author":"Clark","year":"1990","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2021.08.002_bib0620","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0035-3787(04)70932-7","article-title":"Pandysautonomie paran\u00e9oplasique avec anticorps anti-Hu\u00a0: r\u00e9v\u00e9lation d\u2019un ad\u00e9nocarcinome bronchique par le PET scan","volume":"160","author":"Guilloton","year":"2004","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jfo.2021.08.002_bib0625","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.lpm.2018.01.006","article-title":"Sweet's syndrome with ocular involvement","volume":"47","author":"Kammoun","year":"2018","journal-title":"Presse Med"},{"key":"10.1016\/j.jfo.2021.08.002_bib0630","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1442-9071.2007.01605.x","article-title":"Nodular scleritis and Sweet's syndrome","volume":"35","author":"Wong","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0635","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet syndrome: a review and update","volume":"107","author":"Villarreal-Villarreal","year":"2016","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"10.1016\/j.jfo.2021.08.002_bib0640","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/bjo.2007.115634","article-title":"Cicatrising conjunctivitis due to paraneoplastic pemphigoid","volume":"91","author":"Rutar","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0645","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2133.1999.02933.x","article-title":"Paraneoplastic cicatricial pemphigoid","volume":"141","author":"Setterfield","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0650","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","article-title":"Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations","volume":"40","author":"Kaplan","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0655","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfo.2021.08.002_bib0660","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/CJI.0000000000000278","article-title":"Myasthenia gravis induced by immune checkpoint inhibitors","volume":"42","author":"Becquart","year":"2019","journal-title":"J Immunother"},{"key":"10.1016\/j.jfo.2021.08.002_bib0665","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s40425-019-0774-y","article-title":"Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature","volume":"7","author":"Safa","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jfo.2021.08.002_bib0670","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nmd.2020.02.013","article-title":"Immune checkpoint inhibitors (ICIs)-related ocular myositis","volume":"30","author":"Garibaldi","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jfo.2021.08.002_bib0675","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.semarthrit.2018.05.006","article-title":"Myositis as an adverse event of immune checkpoint blockade for cancer therapy","volume":"48","author":"Shah","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jfo.2021.08.002_bib0680","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1212\/NXI.0000000000000464","article-title":"Granulomatous myositis induced by anti-PD-1 monoclonal antibodies","volume":"5","author":"Uchio","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.jfo.2021.08.002_bib0685","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00041327-200406000-00004","article-title":"Bilateral horizontal gaze palsy in presumed paraneoplastic brainstem encephalitis associated with a benign ovarian teratoma","volume":"24","author":"Muni","year":"2004","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0690","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3892\/ol.2014.2454","article-title":"Isolated oculomotor nerve palsy as a paraneoplastic manifestation of gastric diffuse large B-cell lymphoma: a case report","volume":"8","author":"Yan","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jfo.2021.08.002_bib0695","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jfo.2021.08.002_bib0700","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1749-6632.2011.06113.x","article-title":"Paraneoplastic disorders of eye movements: paraneoplastic upbeat nystagmus","volume":"1233","author":"Wray","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jfo.2021.08.002_bib0705","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5693\/djo.02.2013.10.002","article-title":"Ocular flutter as the presenting sign of lung adenocarcinoma","volume":"20","author":"Cestari","year":"2014","journal-title":"Digit J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0710","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","article-title":"Update on opsoclonus\u2013myoclonus syndrome in adults","volume":"266","author":"Oh","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0715","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0883073812471433","article-title":"Clinical profile and outcome of children with opsoclonus-myoclonus syndrome","volume":"29","author":"Singhi","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0720","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","article-title":"Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus","volume":"22","author":"Antunes","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0725","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.1288","article-title":"J. Dalmau. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins","volume":"50","author":"Rosenfeld","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0730","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14737175.2016.1176914","article-title":"Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment","volume":"16","author":"Blaes","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jfo.2021.08.002_bib0735","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/01.wnl.0000237558.83349.d0","article-title":"Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies","volume":"67","author":"Rakocevic","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0740","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08998280.2015.11929234","article-title":"Paraneoplastic cerebellar ataxia and the paraneoplastic syndromes","volume":"28","author":"Afzal","year":"2015","journal-title":"Proc Bayl Univ Med Cent"},{"key":"10.1016\/j.jfo.2021.08.002_bib0745","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/practneurol-2013-000524","article-title":"Upbeat nystagmus in anti-Ma2 encephalitis","volume":"14","author":"Garcia-Reitboeck","year":"2014","journal-title":"Pract Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0750","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3129\/i08-026","article-title":"Paraneoplastic downbeat nystagmus","volume":"43","author":"Bussi\u00e8re","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0755","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/WNL.0b013e3182583085","article-title":"Positional periodic alternating vertical nystagmus with PCA-Tr antibodies in Hodgkin lymphoma","volume":"78","author":"Eggers","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0760","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archneur.62.8.1300","article-title":"Anti-GAD antibodies and periodic alternating nystagmus","volume":"62","author":"Tilikete","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0765","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0770","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jfo.2021.08.002_bib0775","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.wno.0000235564.50518.1b","article-title":"Pupil abnormalities in selected autonomic neuropathies","volume":"26","author":"Bremner","year":"2006","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0780","first-page":"197","article-title":"[Paraneoplastic neuropathy with positive anti-Hu]","volume":"58","author":"Casas Parera","year":"1998","journal-title":"Medicina (Mex.)"},{"key":"10.1016\/j.jfo.2021.08.002_bib0785","first-page":"510","article-title":"Pupillary fatigue in myasthenia gravis","volume":"102","author":"Dutton","year":"1982","journal-title":"Trans Ophthalmol Soc U K"},{"key":"10.1016\/j.jfo.2021.08.002_bib0790","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.clineuro.2005.07.009","article-title":"Adie's pupils in paraneoplastic ganglionopathy with ANNA-1","volume":"108","author":"Campellone","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jfo.2021.08.002_bib0795","first-page":"141","article-title":"Bilateral tonic pupils with evidence of anti-Hu antibodies as a paraneoplastic manifestation of small cell lung cancer","volume":"218","author":"Wabbels","year":"2004","journal-title":"Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd"},{"key":"10.1016\/j.jfo.2021.08.002_bib0800","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.survophthal.2012.09.001","article-title":"Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management","volume":"58","author":"Rahimy","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0805","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00005-007-0026-6","article-title":"Cancer-associated retinopathy in patients with breast carcinoma","volume":"55","author":"Misiuk-Hoj\u0142o","year":"2007","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jfo.2021.08.002_bib0810","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/09273940903457441","article-title":"Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer","volume":"18","author":"Kim","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2021.08.002_bib0815","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-008-0114-7","article-title":"Autoimmune retinopathy: a review and summary","volume":"30","author":"Heckenlively","year":"2008","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0820","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9394(98)00149-4","article-title":"Recoverin-associated retinopathy: a clinically and immunologically distinctive disease","volume":"126","author":"Whitcup","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0825","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/jaut.1998.0221","article-title":"Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo","volume":"11","author":"Adamus","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jfo.2021.08.002_bib0830","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajo.2004.12.104","article-title":"Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies","volume":"139","author":"Weleber","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0835","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ijc.23909","article-title":"Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy","volume":"124","author":"Bazhin","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jfo.2021.08.002_bib0840","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCO.0000000000000296","article-title":"Ocular and orbital side effects of checkpoint inhibitors: a review article","volume":"28","author":"Antoun","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0845","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.survophthal.2012.02.004","article-title":"Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature","volume":"57","author":"Aronow","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0850","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0002-9394(73)90578-3","article-title":"Retinopathy in childhood dermatomyositis","volume":"76","author":"Harrison","year":"1973","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0855","series-title":"Dermatomyositis: advances in recognition, understanding and management","first-page":"93","article-title":"Ophthalmic complications of dermatomyositis","author":"Dourmishev","year":"2009"},{"key":"10.1016\/j.jfo.2021.08.002_bib0860","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ophtha.2019.09.012","article-title":"Collapsin response mediator protein 5-associated retinitis, vitritis, and optic disc edema","volume":"127","author":"Cohen","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0865","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(93)90176-Y","article-title":"Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina","volume":"117","author":"Antoine","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfo.2021.08.002_bib0870","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0875","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0880","series-title":"Uveitis update: proceedings of the international symposium on uveitis","first-page":"407","article-title":"Acute Vogt-Koyanagi-Harada-like syndrome occurring in a patient with metastatic cutaneous melanoma","author":"Gass","year":"1984"},{"key":"10.1016\/j.jfo.2021.08.002_bib0885","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/09273948.2019.1597896","article-title":"Development of acute Vogt-Koyanagi-Harada-like syndrome during the treatment course with vemurafenib for metastatic melanoma","volume":"28","author":"Apivatthakakul","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2021.08.002_bib0890","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.survophthal.2003.08.005","article-title":"Bilateral diffuse uveal melanocytic proliferation associated with pancreatic carcinoma: a case report and literature review of this paraneoplastic syndrome","volume":"48","author":"O\u2019Neal","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0895","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1990.01070060075053","article-title":"Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma","volume":"108","author":"Gass","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0900","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/eye.2013.131","article-title":"Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation","volume":"27","author":"Pulido","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2021.08.002_bib0905","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/bjophthalmol-2014-305893","article-title":"Early diagnosis and successful treatment of paraneoplastic melanocytic proliferation","volume":"99","author":"Jansen","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0910","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/WNO.0000000000000458","article-title":"Paraneoplastic optic neuropathy associated with purkinje cell antibody-2 in a patient with small cell lung cancer","volume":"37","author":"Micieli","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0915","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4","article-title":"New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity","volume":"47","author":"Vernino","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0920","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jocn.2017.10.030","article-title":"Paraneoplastic neuromyelitis optica spectrum disorder: a case report and review of the literature","volume":"48","author":"Annus","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jfo.2021.08.002_bib0925","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.msard.2017.12.012","article-title":"Paraneoplastic Neuromyelitis Optica Spectrum Disorder: a single center cohort description with two cases of histological validation","volume":"20","author":"Beauchemin","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jfo.2021.08.002_bib0930","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1352458517731914","article-title":"Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"10.1016\/j.jfo.2021.08.002_bib0935","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0940","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/01658107.2016.1262431","article-title":"Optic neuropathy as the initial presenting sign of N-methyl-d-aspartate (NMDA) encephalitis","volume":"41","author":"Mugavin","year":"2017","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.jfo.2021.08.002_bib0945","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00415-018-9110-6","article-title":"POEMS syndrome: clinical update","volume":"266","author":"Brown","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0950","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00415-013-7143-4","article-title":"Papilloedema is an independent prognostic factor for POEMS syndrome","volume":"261","author":"Cui","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0955","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0035-3787(05)84978-1","article-title":"[Anti-Ri paraneoplastic syndrome associated with ophtalmoplegia, blepharospasm and palilalia]","volume":"161","author":"Martinaud","year":"2005","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jfo.2021.08.002_bib0960","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00003226-200007000-00033","article-title":"Remission of antiepiligrin (Laminin-5) cicatricial pemphigoid after excision of gastric carcinoma","volume":"19","author":"Uchiyama","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2021.08.002_bib0965","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/pbc.20899","article-title":"Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus","volume":"50","author":"Bell","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jfo.2021.08.002_bib0970","first-page":"653","article-title":"[Clinical diagnosis and treatment recommendations for ocular toxicities of target therapy and immune checkpoint inhibitor therapy]","volume":"22","author":"Liu","year":"2019","journal-title":"Zhongguo Fei Ai Za Zhi Chin J Lung Cancer"},{"key":"10.1016\/j.jfo.2021.08.002_bib0975","first-page":"705","article-title":"Mechanisms of photoreceptor cell death in cancer-associated retinopathy","volume":"42","author":"Maeda","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2021.08.002_bib0980","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12348-012-0067-9","article-title":"Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy","volume":"2","author":"Huynh","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2021.08.002_bib0985","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1073\/pnas.0911661107","article-title":"VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy","volume":"107","author":"Cao","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jfo.2021.08.002_bib0990","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamaophthalmol.2019.0284","article-title":"Outcomes associated with sustained-release intraocular fluocinolone implants in a case of melanoma-associated retinopathy treated without systemic immunosuppression","volume":"137","author":"Karatsai","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.002_bib0995","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1136\/jnnp-2012-304874","article-title":"Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome","volume":"84","author":"Sekiguchi","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jfo.2021.08.002_bib0500","doi-asserted-by":"crossref","DOI":"10.1038\/sj.eye.6702959","article-title":"Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes","volume":"22","author":"Pulido","year":"2008","journal-title":"Eye"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551221004423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551221004423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:16:27Z","timestamp":1759259787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551221004423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0181551221004423"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2021.08.002","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophtalmies paran\u00e9oplasiques","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2021.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}